Araim Pharmaceuticals, Inc.的封面图片
Araim Pharmaceuticals, Inc.

Araim Pharmaceuticals, Inc.

生物技术研究

Tarrytown,New York 288 位关注者

Repairing the damage caused by disease

关于我们

Our mission is to create a new category of therapeutics that repair the damage caused by devastating diseases. Our core innovation is the discovery of a global master regulator, the Innate Repair Receptors (IRR), that produces cellular and tissue repair in various disease states. Our lead compound in clinical development, Cibinetide, is focused on addressing unmet needs in neuroscience and diabetes complications. We have developed an extensive peptide library of IRR activators, with in-vivo proof of concept efficacy for 10 unique compounds and an extensive catalogue of scientific literature in collaboration with leading academic researchers around the globe.

网站
https://araimpharma.com
所属行业
生物技术研究
规模
2-10 人
总部
Tarrytown,New York
类型
私人持股
创立
2006

地点

  • 主要

    580 White Plains Rd

    Suite 210

    US,New York,Tarrytown,10591

    获取路线

相似主页

查看职位

融资